timothy sykes logo

Stock News

cbdMD’s NYSE Compliance Resolved and Positive Revenue Forecast Ignites Optimism

Bryce TuoheyAvatar
Written by Bryce Tuohey Reviewed by Tim Sykes Fact-checked by Matt Monaco
Updated 12/14/2025, 8:11 am ET 12/14/2025, 8:11 am ET | 5 min 5 min read
cbdMD’s NYSE Compliance Resolved and Positive Revenue Forecast Ignites Optimism Thumbnail

cbdMD Inc. stocks have been trading up by 74.33 percent due to optimistic market sentiment from significant industry developments.

Healthcare industry expert:

Analyst sentiment – positive

  1. Market Position & Fundamentals: cbdMD (YCBD) is facing significant financial hurdles with negative profitability margins, including an alarming pre-tax profit margin of -85.3%. The company’s income statements show a concerning decrease in revenues over three and five years, indicating market position challenges. Valuation measures, like a price-to-sales ratio of 0.56, reflect undervaluation due to operational struggles. Financial strength metrics such as a manageable total debt-to-equity ratio of 0.16 offer a sliver of resilience. However, the return on equity of -84.76% and return on assets of -63.1% highlight significant inefficiencies, pointing to a weak competitive stance within the Healthcare sector.

  2. Technical Analysis & Trading Strategy: Recent weekly price action for cbdMD exhibits volatility, with a notable surge on December 11th, witnessing a sharp incline to $0.9758 and a significant rise to $1.1 the following day. This upward momentum is indicative of bullish sentiment, fueled possibly by recent news or speculative trading. The analysis of 5-minute candle patterns shows high trading volume during these spikes, reinforcing a bullish trend. A prudent trading strategy involves entering a buy position at current support levels around $0.9758, setting a target to the recent high of $1.43, while placing a stop-loss slightly below $0.9758 to mitigate potential downturn risk.

  3. Catalysts & Outlook: cbdMD’s recent updates reveal progress, notably with a forecast of slight revenue decline for FY25 yet predicting a narrower net loss, improving from ($3.7M) to ($1.9M)-($2.1M). Gaining full compliance with NYSE American listing standards is a critical achievement, indicating strategic financial recovery, including debt management and capital restructuring. Despite the broader sector downturns of 8-10%, cbdMD stands out with an optimistic outlook due to its commitment to cost efficiency and operational improvements. The near-term resistance is set at $1.43, with a short-term support around $1.1. Overall, cbdMD shows signs of recovery against industry benchmarks, presenting a cautiously optimistic outlook.

Candlestick Chart

Weekly Update Dec 08 – Dec 12, 2025: On Sunday, December 14, 2025 cbdMD Inc. stock [NYSE American: YCBD] is trending up by 74.33%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

In the fourth quarter, cbdMD has forecasted an upswing in their revenue margin, projected at $4.7M to $4.9M, a slight increase from $4.6M the previous year. These figures, though not explosive, indicate a positive momentum. The estimated revenue for the full year 2025 is between $19.1M to $19.3M, signifying a tightening of operations but improving fiscal losses to a band of ($1.9M) to ($2.1M) from the previous ($3.7M). This improvement stems from disciplined cost management strategies sharply contrasting with sectorial declines of 8% to 10%.

More Breaking News

Financial reports highlight a profitable stance in the cbd sector despite competitive pressures, thanks in part to a 3%-5% increase in fourth-quarter net sales. Key financial ratios show mixed results, with gross margins at a solid 61.2%, though profitability metrics suggest ongoing challenges as demonstrated by ebitmargin at -8.1 and a profitmargintot at -25.5. Investments in operational efficiency and strategic alignment to enhance long-term shareholder value remain a focal point.

Conclusion

The road ahead for cbdMD is paved with cautious optimism. The resolution of NYSE listing issues boosts trader sentiment. The better-than-anticipated Q4 revenue aligns with internal efficiencies and strategic venturing beyond historical fiscal shortfalls. Maintaining this upward trajectory calls for a heightened focus on leveraging market dynamics and capital competencies. As the company navigates the nuanced cbd marketplace, its strategic financial management and compliance standing could well underpin a robust position in future market expansions. As millionaire penny stock trader and teacher Tim Sykes says, “Embrace the journey, the ups and downs; each mistake is a lesson to improve your strategy.” This mindset is crucial for cbdMD as it adapts and responds to the dynamic conditions of the marketplace.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply
Author card Timothy Sykes picture

Bryce Tuohey

Mentor and Trainer at StocksToTrade.com, Lead Mentor at Small Cap Rockets and To The Moon Report
Bryce’s first pattern was buying into strength in breakouts. But he noticed when they didn’t work, he took bigger losses. When the OTC market got hot, Bryce learned to dip buy the inevitable panics. He adapted his breakout strategy and now buys consolidation and trend breaks. His goal is to have better risk/reward and get an entry before multi-day listed breakouts.
Read More

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”